Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice

Journal of Neuro-Oncology

Volumn 96, Issue 2, 2010, Pages 249-257

  Van Genugten, J A B ^a   Leffers, P ^b   Baumert, B G ^a   Tjon A Fat, H ^a   Twijnstra, A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Glioblastoma multiforme; Radiotherapy; Routine clinical practice; Survival; Temozolomide

Indexed keywords

ANTICONVULSIVE AGENT; TEMOZOLOMIDE; VALPROIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SALVAGE THERAPY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 75049083185     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9956-7     Document Type: Article

References (27)

1. H Ohgaki P Kleihues 2005 Epidemiology and etiology of gliomas Acta Neuropathol 109 1 93 108 10.1007/s00401-005-0991-y 15685439 (Pubitemid 40287792)
2. DN Louis H Ohgaki OD Wiestler WK Cavenee PC Burger A Jouvet, et al. 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2 97 109 10.1007/s00401-007-0243-4 17618441
3. ER Laws IF Parney W Huang F Anderson AM Morris A Asher, et al. 2003 Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project J Neurosurg 99 3 467 473 10.3171/jns.2003.99.3.0467 12959431 see comment
4. WJ Curran Jr CB Scott J Horton JS Nelson AS Weinstein AJ Fischbach, et al. 1993 Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 9 704 710 10.1093/jnci/85.9.704 8478956 see comment
5. M Lacroix D Abi-Said DR Fourney ZL Gokaslan W Shi F DeMonte, et al. 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2 190 198 10.3171/jns.2001.95. 2.0190 1:STN:280:DC%2BD38%2FlsFGitA%3D%3D 11780887 see comment
6. FW Kreth PC Warnke R Scheremet CB Ostertag 1993 Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme J Neurosurg 78 5 762 766 10.3171/jns.1993.78.5.0762 1:STN:280:DyaK3s3isV2ktg%3D%3D 8385709
7. CH Chang J Horton D Schoenfeld O Salazer R Perez-Tamayo S Kramer, et al. 1983 Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study Cancer 52 6 997 1007 10.1002/1097-0142(19830915)52: 6<997::AID-CNCR2820520612>3.0.CO;2-2 1:STN:280:DyaL3s3osVOmuw%3D%3D 6349785 Sep 15
8. M Sandberg-Wollheim P Malmstrom LG Stromblad H Anderson S Borgstrom A Brun, et al. 1991 A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4 Cancer 68 1 22 29 10.1002/1097-0142(19910701)68:1<22::AID- CNCR2820680105>3.0.CO;2-2 1:STN:280:DyaK3M3ms1ahsw%3D%3D 2049748
9. BJ Slotman JH Kralendonk HA van Alphen W Kamphorst AB Karim 1996 Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors Int J Radiat Oncol Biol Phys 34 4 895 898 1:STN:280:DyaK287nsFaluw%3D%3D 8598367
10. BC Devaux JR O'Fallon PJ Kelly 1993 Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome J Neurosurg 78 5 767 775 10.3171/jns.1993.78.5.0767 1:STN:280:DyaK3s3isV2ktw%3D%3D 8468607
11. WR Shapiro SB Green PC Burger MS Mahaley Jr RG Selker JC VanGilder, et al. 1989 Randomized trial of three chemotherapy regimens, two radiotherapy regimens, two radiotherapy regimens in postoperative treatment of malignant glioma Brain Tumor Cooperative Group Trial 8001 J Neurosurg 71 1 1 9 10.3171/jns.1989.71.1.0001 1:STN:280:DyaL1M3ptlajtg%3D%3D 2661738
12. W Stummer HJ Reulen T Meinel U Pichlmeider W Schumacher JC Tonn, et al. 2008 Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 62 3 564 576 10.1227/01.neu.0000317304. 31579.17 18425006
13. T Gorlia MJ van den Bent ME Hegi RO Mirimanoff M Weller JG Cairncross, et al. 2008 Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 Lancet Oncol 9 1 29 38 10.1016/S1470-2045(07)70384-4 18082451 see comment
14. MD Walker SB Green DP Byar E Alexander Jr U Batzdorf WH Brooks, et al. 1980 Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 23 1323 1329 1:STN:280:DyaL3M%2Flt1Wiuw%3D%3D 7001230
15. HA Fine KB Dear JS Loeffler PM Black GP Canellos 1993 Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 8 2585 2597 10.1002/1097-0142(19930415)71:8<2585::AID- CNCR2820710825>3.0.CO;2-S 1:STN:280:DyaK3s3gtFCrtQ%3D%3D 8453582 see comment
16. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 9311 1011 1018 10.1016/S0140-6736(02)08091-1 1:CAS:528: DC%2BD38XisV2htro%3D 11937180 (Pubitemid 34286538)
17. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009 see comment (Pubitemid 40349501)
18. H Athanassiou M Synodinou E Maragoudakis M Paraskevaidis C Verigos D Misailidou, et al. 2005 Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme J Clin Oncol 23 10 2372 2377 10.1200/JCO.2005.00.331 1:CAS:528:DC%2BD2MXjsVyhsrg%3D 15800329 Apr 1 (Pubitemid 46218731)
19. WK Yung RE Albright J Olson R Fredericks K Fink MD Prados, et al. 2000 A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 5 588 593 10.1054/bjoc.2000.1316 1:CAS:528:DC%2BD3cXmvVCgsrs%3D 10944597
20. S Ostermann C Csajka T Buclin S Leyvraz F Lejeune LA Decosterd, et al. 2004 Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients Clin Cancer Res 10 11 3728 3736 10.1158/1078-0432.CCR-03-0807 1:CAS:528:DC%2BD2cXksVKntrw%3D 15173079 Jun 1 (Pubitemid 38697606)
21. C Irwin M Hunn G Purdie D Hamilton 2007 Delay in radiotherapy shortens survival in patients with high grade glioma J Neurooncol 85 3 339 343 10.1007/s11060-007-9426-z 17579810 (Pubitemid 350142524)
22. V Do V Gebski MB Barton 2000 The effect of waiting for radiotherapy for grade III/IV gliomas Radiother Oncol 57 2 131 136 10.1016/S0167-8140(00)00257-7 1:STN:280:DC%2BD3M%2FovFensg%3D%3D 11054516 see comment (Pubitemid 30774668)
23. NG Burnet R Jena SJ Jefferies SP Stenning NF Kirkby 2006 Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment Clin Oncol (R Coll Radiol) 18 2 93 103 1:STN:280:DC%2BD287js1Cntw%3D%3D see comment
24. J Lutterbach 2003 Live fast, die early? The deleterious effects of waiting time in patients with glioblastoma Anticancer Drugs 14 6 447 448 10.1097/00001813-200307000-00010 1:CAS:528:DC%2BD3sXlsVeht7o%3D 12853887 (Pubitemid 36951796)
25. DT Blumenthal M Won MP Mehta WJ Curran L Souhami JM Michalski, et al. 2009 Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database J Clin Oncol 27 5 733 739 10.1200/JCO.2008.18.9035 19114694
26. CR Miller A Perry 2007 Glioblastoma Arch Pathol Lab Med 131 3 397 406 17516742
27. JC Margetts UP Kalyan-Raman 1989 Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure) Cancer 63 3 524 531 10.1002/1097-0142(19890201)63:3<524::AID-CNCR2820630321>3.0.CO;2-D 1:STN:280:DyaL1M7gs1SrsQ%3D%3D 2912529 (Pubitemid 19038469)